Loading…
Loading…
Loading…
Tirzepatide
Mounjaro is a once-weekly injection designed to support weight management by reducing cravings, lowering appetite, and helping you feel fuller for longer.

| Dosage | Price |
|---|---|
| 2.5 mg | £189 |
| 5 mg | £209 |
| 7.5 mg | £259 |
| 10 mg | £289 |
| 12.5 mg | £315 |
| 15 mg | £329 |
Active Ingredient
Tirzepatide
Brand
Eli Lilly
Drug Class
GIP/GLP-1 receptor agonist
Administration
Injection – sub-cutaneous (once-weekly)
Prescription Status
Prescription Only Medicine (POM)
Dosage Form
Pre-filled pen for weekly injection
Strengths Available
2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg
Up to around 22% of starting body weight over ~72 weeks in major trials (varies by individual).
Best results when paired with diet, exercise and healthy habits.
Duration & Size
72 weeks, ~2,539 people
Highest Avg Weight Loss
≈-22.5% (15 mg)
Common Side Effects
Nausea, Diarrhoea, Constipation
Key Takeaway
Up to 57% lost ≥20% of body weight.
Duration & Size
72 weeks, ~938 people
Highest Avg Weight Loss
≈-14.7% (15 mg)
Common Side Effects
Nausea, Diarrhoea, Vomiting
Key Takeaway
Strong results in people with type 2 diabetes.
Duration & Size
72 weeks, ~806 people (after lifestyle run-in)
Highest Avg Weight Loss
≈-21.1%
Common Side Effects
Nausea, Diarrhoea, Constipation
Key Takeaway
Effective even after structured diet/exercise.
Duration & Size
36 weeks open-label + 52 weeks randomised (~700 people)
Highest Avg Weight Loss
≈-21% (first 36 weeks)
Common Side Effects
Nausea, Diarrhoea, Vomiting
Key Takeaway
Long-term maintenance: staying on treatment supports weight maintenance; stopping may lead to regain.
Injection once a week. Titration is used to increase gradually from low dose to maintenance.
| Weeks | Dose | Frequency |
|---|---|---|
| 1-4 | 2.5 mg | Once a week |
| 5-8 | 5 mg | Once a week |
| 9-12 | 7.5 mg | Once a week |
| 13-16 | 10 mg | Once a week |
| 17-20 | 12.5 mg | Once a week |
| 21+ | 15 mg | Once a week |
Important: Your prescriber will decide when to increase dose based on your response and side-effects.
Some appetite reduction may occur from first dose. Weight loss typically becomes more visible after several months.
Eli Lilly (pharmaceutical company founded 1876)
Available privately in the UK through an online consultation with a UK-based qualified prescriber.
Eligible under NHS by NICE TA1026 only for adults with BMI ≥35 kg/m² and at least one weight-related comorbidity; access is phased and prioritised for those with highest clinical need.
From March/June 2025 onwards in NHS specialist weight management services and subsequently primary care.
Common site; may have slightly higher appetite-suppression but more side-effects.
Alternative site.
Alternative; some data suggest slightly lower appetite-suppression effect compared with abdomen.
More than 10% of people experience the most common side effects of taking Mounjaro. This usually happens when first starting treatment and increasing the dose. These side effects are usually gastrointestinal (affecting the digestive system) and can be managed at home with over-the-counter treatments or lifestyle changes. Most of these side effects are usually mild and go away on their own as your body gets used to treatment. But if you're finding them too difficult to manage or they're getting worse, you should speak to your clinician.
Serious side effects are extremely rare, but it is important to know the signs so you can get help if you need it.
ⓘPancreatitis
Long-lasting pain in your stomach or back which can be severe.
ⓘGallbladder problems
Symptoms may include pain in the upper right abdomen, nausea, or fever.
ⓘAllergic reactions
Stop taking Mounjaro and seek medical help immediately if you experience breathing problems, wheezing, swelling, or severe dizziness.
Injection site reactions are a common side effect of Mounjaro. They usually appear as rashes, bruising, or swelling where you've been injecting. You can reduce this by changing injection sites regularly and making sure your injection sites are clean. If you're concerned about needles containing nickel, our needles only contain trace amounts, which you are not exposed to while injecting. There is no residue left behind that contains nickel.
Most common side effects of Mounjaro settle down or go away within a few days or weeks as your body adjusts to the medication. However, everyone's experience is different, so this isn't always the case. Side effects can also return or start when changing dose. If side effects don't go away or worsen, it's important to speak to your prescriber.
While more data is needed to say for sure, there are currently no reported long-term side effects caused directly by taking Mounjaro.
Losing weight too quickly can lead to muscle loss, excess skin, a slower metabolism, and nutrient deficiencies. It can also increase the risk of side effects like gallstones, fatigue, and dehydration. On top of that, it may negatively affect your mental health, leading to anxiety and stress. Rapid weight loss can also make it harder to maintain your results, especially after coming off treatment. That's why we support you in building a plan that promotes safe, sustainable weight loss at a pace you can maintain.
Keep in fridge (2-8°C) until first use; after first use follow manufacturer instructions for room-temperature storage.
Carry in a cooler bag if needed. Avoid freezing or high heat exposure.
Risk: Rapid weight loss can include reduction in lean mass (~10.9% in one study).
Advice: Include protein, strength-training and discuss supplements with your prescriber if needed.
| Product | Active Ingredient | Mechanism | Dose | Weight Loss Potential |
|---|---|---|---|---|
| Mounjaro | Tirzepatide | Dual-GIP + GLP-1 agonist | Up to 15 mg once a week | Up to ~22% in trials |
| Wegovy | Semaglutide | GLP-1 agonist | Up to 2.4 mg once a week | Around ~15-17% |
| Saxenda | Liraglutide | GLP-1 agonist (daily injection) | — | Around ~8-10% |
Note: Mounjaro may offer stronger weight-loss for some people, but choice should be guided by your clinician based on suitability, side-effect profile and cost.
Common questions about the product. If you have more questions, please contact our support team or book a consultation with one of our clinicians.
This information is for general educational purposes only and not a substitute for personalised medical advice. Suitability, dose, monitoring and side-effect risk must be determined by a qualified prescriber under UK regulatory guidance (MHRA, NICE).